Picture of Intra-Cellular Therapies logo

ITCI — Intra-Cellular Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Intra-Cellular Therapies Upon Termination Of Deal, To Pay Johnson & Johnson Termination Fee Of $475.5 Million

Jan 13 (Reuters) - Intra-Cellular Therapies Inc
 ITCI.O :
    * INTRA-CELLULAR THERAPIES: UPON TERMINATION OF DEAL, UNDER
SPECIFIED CIRCUMSTANCES, CO TO PAY JOHNSON & JOHNSON TERMINATION
FEE OF $475.5 MILLION

Further company coverage:  ITCI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Intra-Cellular Therapies

See all news